论文部分内容阅读
为了解卡氏肺孢子虫肺炎(PCP)在病人中的危险性及评估化学预防的可能作用,作者于90年1月至93年4月应用间接免疫荧光法在悉尼对1002份住院病人的呼吸道标本(包括咳痰、诱生痰、支气管肺泡灌洗液、肺活检标本),进行肺孢子虫检测。确诊的PCP为92例,其中HIV阳性者64例,HIV阴性者28例。HIV阴性患者中肾移植者9例,肝移植者6例,与血液系统有关的恶性肿瘤患者4例(多发性骨髓瘤2例,Hodgkin′s病1
To understand the risk of Pneumocystis carinii pneumonia (PCP) in patients and to evaluate the possible role of chemoprevention, the authors used indirect immunofluorescence in Sydney from January 1990 to April 1993 in 1002 inpatient respiratory Specimens (including sputum, induced sputum, bronchoalveolar lavage fluid, lung biopsy specimens), detection of Pneumocystis. The diagnosis of PCP was 92 cases, of which 64 were HIV-positive, HIV-negative in 28 cases. Among the HIV-negative patients, 9 were renal transplant recipients, 6 were liver transplant recipients, and 4 were malignant tumor-associated patients (2 with multiple myeloma, 1 with Hodgkin’s disease